Kazia Therapeutics
KZIA
7 hedge funds and large institutions have $279K invested in Kazia Therapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.
7% more capital invested
Capital invested by funds: $262K → $279K (+$17.4K)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
22% less funds holding
Funds holding: 9 → 7 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$192 |
| 2 |
AF
Allworth Financial
Folsom,
California
|
+$96 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$55.6K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$34.5K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$26.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$7.52K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.94K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $205K | -$55.6K | -1,158 | -22% |
|
|
2
Acadian Asset Management
Boston,
Massachusetts
| $70K | -$34.5K | -719 | -35% |
|
|
BAM
3
Belpointe Asset Management
Reno,
Nevada
| $3.09K | – | – | – |
|
|
NA
4
NewEdge Advisors
New Orleans,
Louisiana
| $515 | – | – | – |
|
|
5
Bank of America
Charlotte,
North Carolina
| $206 | +$192 | +4 | New |
|
|
AF
6
Allworth Financial
Folsom,
California
| $90 | +$96 | +2 | New |
|
|
SPIA
7
Steward Partners Investment Advisory
New York
| $26 | -$48 | -1 | -50% |
|
|
AF
8
Advisornet Financial
Minnetonka,
Minnesota
| $5 | – | – | – |
|
|
OMC
9
Old Mission Capital
Chicago,
Illinois
| – | -$26.3K | -855 | Closed |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$7.52K | -245 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$3.94K | -127 | Closed |
|
12
Wells Fargo
San Francisco,
California
| – | -$123 | -4 | Closed |
|
KZIA Hedge Fund Activity: Q1 2023 in Review
7 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q1 2023, worth a combined $279K — up 6.6% from $262K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of KZIA and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 0 added.
The largest buyer was Bank of America, opening a new position worth an estimated $192. The largest seller was Morgan Stanley, cutting an estimated $55.6K.
- 7 institutional investors held Kazia Therapeutics (KZIA) as of Q1 2023, down from 9 in Q4 2022.
- Funds reported $279K of Kazia Therapeutics stock for Q1 2023, up 6.6% quarter-over-quarter.
- 2 funds opened new Kazia Therapeutics positions in Q1 2023 and 4 closed out, a net change of -2 holders.
- The largest Kazia Therapeutics buyer in Q1 2023 was Bank of America, an estimated $192 added.
- The largest Kazia Therapeutics seller in Q1 2023 was Morgan Stanley, an estimated $55.6K sold.
Based on aggregated 13F filings for Q1 2023.